Delcath Systems (DCTH) Announces 8.5M Common Stock Offering
Up)
Delcath Systems, Inc. (NASDAQ: DCTH) announced an offering of 8.5 million shares of its common stock. Delcath also intends to grant the underwriters of the offering an option to purchase up to 15% of additional shares of primary stock to cover over-allotments.
Delcath plans to use the proceeds from the offering for general corporate purposes including regulatory approval, commercialization, clinical trials, capital expenditures and working capital.
Cowen and Company, LLC is acting as the sole book-running manager on the offering. Canaccord Adams, Wedbush PacGrow Life Sciences and Craig-Hallum Capital Group are acting as co-managers.
Delcath plans to use the proceeds from the offering for general corporate purposes including regulatory approval, commercialization, clinical trials, capital expenditures and working capital.
Cowen and Company, LLC is acting as the sole book-running manager on the offering. Canaccord Adams, Wedbush PacGrow Life Sciences and Craig-Hallum Capital Group are acting as co-managers.
You May Also Be Interested In
- Delcath Systems (DCTH) Announces Common, Warrants Offering
- BlackRock (BLK) Lower After Pricing Massive Secondary Offering
- Synageva BioPharma (GEVA) Files $150M Mixed Shelf
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Canaccord Adams, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
